Logo image of ROMJ.CA

RUBICON ORGANICS INC (ROMJ.CA) Stock Earnings & Estimates

Canada - TSX-V:ROMJ - CA78112W1005 - Common Stock

0.49 CAD
+0.01 (+2.08%)
Last: 11/7/2025, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
ROMJ.CA revenue by date.ROMJ.CA revenue by date.
35.518M
57.08%
40.117M
12.95%
48.696M
21.39%
59.792M
22.79%
75.043M
25.51%
103.32M
37.68%
EBITDA
YoY % growth
ROMJ.CA ebitda by date.ROMJ.CA ebitda by date.
15.168M
13,216.86%
14.283M
-5.84%
15.108M
5.78%
4.394M
-70.92%
11.767M
167.80%
17.372M
47.63%
EBIT
YoY % growth
ROMJ.CA ebit by date.ROMJ.CA ebit by date.
12.118M
630.88%
11.159M
-7.91%
11.837M
6.08%
404K
-96.59%
8.989M
2,125.00%
13.231M
47.19%
Operating Margin
ROMJ.CA operating margin by date.ROMJ.CA operating margin by date.
34.12%27.82%24.31%0.68%11.98%12.81%
EPS
YoY % growth
ROMJ.CA eps by date.ROMJ.CA eps by date.
N/A
92.59%
N/A
-100.00%
N/A0.00
100.00%
0.080.20
166.67%

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.010.010.010.03
203.00%
0.03
500.00%
0.04
700.00%
Revenue
Q2Q % growth
15.655M
15.97%
16.025M
12.85%
15.958M
28.94%
17.827M
18.97%
18.635M
19.04%
20.655M
28.89%
EBITDA
Q2Q % growth
1.313M
-76.40%
1.414M
-81.80%
1.717M
-50.87%
2.576M
-58.38%
2.879M
119.27%
3.939M
178.57%
EBIT
Q2Q % growth
303K
-90.37%
454.5K
-89.89%
909K
-66.71%
1.717M
-62.59%
2.02M
566.67%
3.03M
566.67%

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
0.01 0.010.00-0.99%
Q4 2023
Q2Q % growth

200.00%
0.02%
Q3 2023
Q2Q % growth

-74.75%
0.01%
Q2 2023
Q2Q % growth

100.00%
0.00%
Q1 2023
Q2Q % growth

49.50%
-0.01%
Q4 2022
Q2Q % growth

32.67%
-0.02%
Q3 2022
Q2Q % growth
0.04
157.14%
-0.020.06298.02%
Q2 2022
Q2Q % growth
-0.02
77.78%
-0.050.0360.40%
Q1 2022
Q2Q % growth
-0.02 -0.050.0360.40%
Q4 2021
Q2Q % growth
-0.03 -0.040.0125.74%
Q3 2021
Q2Q % growth
-0.07 -0.05-0.02-38.61%
Q2 2021
Q2Q % growth
-0.09 -0.05-0.04-78.22%
Q1 2020
Q2Q % growth
-0.09 -0.05-0.04-78.22%
Q4 2019
Q2Q % growth
-0.02 -0.020.001.04%
ROMJ.CA Yearly EPS VS EstimatesROMJ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2026 2027 0 0.1 -0.1 0.2 -0.2
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
14.984M
23.78%
13.029M1.955M15.00%
Q1 2025
Q2Q % growth
12.376M
39.21%
%
Q4 2024
Q2Q % growth
14.2M
42.10%
%
Q3 2024
Q2Q % growth
13.499M
34.43%
%
Q2 2024
Q2Q % growth
12.106M
7.30%
%
Q1 2024
Q2Q % growth
8.89M
1.03%
%
Q4 2023
Q2Q % growth
9.993M
-9.09%
17.473M-7.48M-42.81%
Q3 2023
Q2Q % growth
10.042M
-4.75%
15.302M-5.26M-34.38%
Q2 2023
Q2Q % growth
11.282M
27.70%
13.13M-1.848M-14.08%
Q1 2023
Q2Q % growth
8.8M
70.93%
11.413M-2.613M-22.90%
Q4 2022
Q2Q % growth
10.992M
61.29%
10.605M387K3.65%
Q3 2022
Q2Q % growth
10.543M
48.69%
10.1M443.1K4.39%
Q2 2022
Q2Q % growth
8.835M
92.24%
7.424M1.411M19.00%
Q1 2022
Q2Q % growth
5.148M
25.24%
5.505M-356.8K-6.48%
Q4 2021
Q2Q % growth
6.815M
42.74%
6.565M250.2K3.81%
Q3 2021
Q2Q % growth
7.091M
123.90%
5.892M1.199M20.34%
Q2 2021
Q2Q % growth
4.596M
363.27%
4.175M420.6K10.07%
Q1 2021
Q2Q % growth
4.111M
805.42%
%
Q4 2020
Q2Q % growth
4.775M 5.151M-376.5K-7.31%
Q3 2020
Q2Q % growth
3.167M 3.939M-772.2K-19.60%
Q2 2020
Q2Q % growth
992K 1.01M-18K-1.78%
Q1 2020
Q2Q % growth
454K 1.564M-1.11M-70.97%
Q4 2019
Q2Q % growth
404K-404K-100.00%
ROMJ.CA Yearly Revenue VS EstimatesROMJ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A 150% N/A 100%
Revenue-1.27% 12.72% 0% 13.63%